<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>TDK Research & Consulting</title>
<link rel="stylesheet" href="style.css">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>

<body>

<header>
  <h1>TDK Research & Consulting</h1>
  <p>AI-designed peptides for blood, bleeding, and thrombosis</p>
</header>

<section id="featured-publications">
  <h2>Featured Publications</h2>
  <div class="carousel-container">
    <div class="carousel-item">
      <strong>AI-generated peptide therapeutics and diagnostics for PT-VWD</strong><br>
      <em>Blood Advances</em> (IF ≈ 7.4, 2026)<br>
      <a href="https://doi.org/10.1182/bloodadvances.2025017674">View paper</a>
    </div>

    <div class="carousel-item">
      <strong>Designing the future of hematology</strong><br>
      <em>Seminars in Thrombosis and Hemostasis</em> (2026, under revision)
    </div>

    <div class="carousel-item">
      <strong>Peptides of a feather: How AI is taking peptide therapeutics under its wing</strong><br>
      <em>Genes</em> (IF ≈ 3.5, 2023)<br>
      <a href="https://doi.org/10.3390/genes14061194">View paper</a>
    </div>

    <div class="carousel-item">
      <strong>Artificial Intelligence Reveals Nature</strong><br>
      <em>International Journal of Molecular Sciences</em> (2025)<br>
      <a href="https://doi.org/10.3390/ijms262110607">View paper</a>
    </div>
  </div>
</section>

<nav>
  <a href="#home">Home</a>
  <a href="#research">Research</a>
  <a href="#technology">Technology</a>
  <a href="#publications">Publications</a>
  <a href="#consulting">Consulting</a>
  <a href="#community">Community</a>
</nav>

<section id="home">
<h2>Welcome</h2>
<p>
TDK Research & Consulting is a translational biomedical research group founded by
<strong>Dr. Thomas Kazmirchuk</strong>. We develop artificial-intelligence–designed peptides
to diagnose and correct dysfunctional blood clotting in rare and acquired bleeding disorders.
</p>
<p>
Our flagship program targets platelet-type von Willebrand disease (PT-VWD), a paradoxical
bleeding disorder driven by gain-of-function mutations in the platelet receptor GPIbα.
</p>
</section>

<section id="research">
<h2>Research Program</h2>
<p>
Blood clotting is governed by a network of protein–protein interactions that must be precisely
balanced. We develop molecular tools that directly target disease-causing binding events.
</p>
</section>

<section id="technology">
<h2>In-Silico Protein Synthesizer (InSiPS)</h2>
<p>
InSiPS is an AI-guided peptide discovery platform that generates highly specific molecules that
bind pathological protein interfaces with therapeutic precision.
</p>
</section>

<section id="publications">
<h2>Publications</h2>
<p>
Peer-reviewed research spanning hemostasis, peptide design, and molecular cell biology.
</p>
</section>

<section id="consulting">
<h2>Consulting</h2>
<p>
Scientific advisory services in protein–protein interactions, AI-driven peptide design,
and translational hematology.
</p>
</section>

<section id="community">
<h2>Community</h2>
<p>
TDK Research supports blood donation initiatives and youth sports leadership in Ottawa.
</p>
</section>

<footer>
<p>© 2026 TDK Research & Consulting</p>
</footer>

</body>
</html>
